CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

Filters:
Show search box
2014-12-05
Nucleolin as a target for anti-cancer therapy

Nucleolin as a target for anti-cancer therapy

Nucleolin, a multifunctional phosphoprotein present mainly in nucleolus, has drawn much attention of molecular biologists due to its role in carcinogenesis and potential of being attractive target for more efficient therapies. As current methods of cancer treatment are still highly unspecific, such a... Read more
Tags nucleolin , cancer , antibody , Bradford Goodwin , therapy
2013-11-04
FDA approves Gazyva – a new treatment of chronic lymphocytic leukaemia

FDA approves Gazyva – a new treatment of chronic lymphocytic leukaemia

On 1 November 2013, Genentech announced that the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab) to be used with chlorambucil chemotherapy for the treatment of chronic lymphocytic leukemia (CLL). ... Read more
Tags cancer , leukemia , CLL , antibody , Genentech , Roche , chemoterapy